Contract Research
Fusion of Technologies Instead of developing commodity products, CCSB focuses on specialty APIs manufactured by a sophisticated fusion of fermentation / synthesis technologies in Taiwan.
The products include:
Immunosuppressants: Mycophenolate mofetil, Rapamycin (Sirolimus) and Tacrolimus Derivative of Rapamycin: Everolimus, Temsirolimus, Zotarolimus and Biolimus Echinocandin: Caspofungin, Micafungin and AnidulafunginFusion of Technologies
Products with Status Development
| Product | CAS | Specification | Status |
|---|---|---|---|
| Everolimus | 9003-97-8 | In-house | Development |
| Caspofungin Acetate | 179463-17-3 | In-house | Development |
| Eletriptan HBr | 177834-92-3 | In-house | Development |
| Temsirolimus | 162635-04-3 | In-house | Development |
Products with Status Investigation
| Product | CAS | Specification | Status |
|---|---|---|---|
| Micafungin Sodium | 208538-73-2 | In-house | Investigation |
| Anidulafungin | 166663-25-8 | In-house | Investigation |
| Zotarolimus | 221877-54-9 | In-house | Investigation |
| Biolimus | 851536-75-9 | In-house | Investigation |